Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

Using difference-in-difference to understand the downside to antibiotic use during infancy

This is a preview of subscription content, access via your institution

Access options

Buy article

Get time limited or full article access on ReadCube.

$32.00

All prices are NET prices.

Fig. 1: A generic illustration of the common trend assumption.

References

  1. Lebeaux, R. M. et al. Impact of antibiotics on off-target infant gut microbiota and resistance genes in cohort studies. Pediatr. Res. https://doi.org/10.1038/s41390-022-02104-w (2022).

  2. Department of Health and Human Services CDC. Antibiotic resistance threats in the United States. (2019).

  3. Yallapragada, S. G., Nash, C. B. & Robinson, D. T. Early-life exposure to antibiotics, alterations in the intestinal microbiome, and risk of metabolic disease in children and adults. Pediatr. Ann. 44, e265–e269 (2015).

    Article  Google Scholar 

  4. Wing, C., Simon, K. & Bello-Gomez, R. A. Designing difference in difference studies: best practices for public health policy research. Annu. Rev. Public Health 39, 453–469 (2018).

    Article  Google Scholar 

  5. Korpela, K. et al. Antibiotics in early life associate with specific gut microbiota signatures in a prospective longitudinal infant cohort. Pediatr. Res. 88, 438–443 (2020).

    Article  CAS  Google Scholar 

  6. Egan, M. et al. Cross-feeding by bifidobacterium breve Ucc2003 during co-cultivation with bifidobacterium bifidum Prl2010 in a mucin-based medium. BMC Microbiol. 14, 282 (2014).

    Article  Google Scholar 

  7. Tawfick, M. M., Elshamy, A. A., Mohamed, K. T. & El Menofy, N. G. Gut commensal Escherichia coli, a high-risk reservoir of transferable plasmid-mediated antimicrobial resistance traits. Infect. Drug Resist. 15, 1077–1091 (2022).

    Article  CAS  Google Scholar 

  8. Poole, N. M., Wattles, B. A. & El Feghaly, R. E. Proposed metrics to benchmark antibiotic prescribing in pediatric outpatient settings. Am. J. Infect. Control 49, 1547–1550 (2021).

    Article  Google Scholar 

  9. Oliver, A. et al. Association of diet and antimicrobial resistance in healthy U.S. adults. mBio 13, e0010122 (2022).

  10. Casaburi, G. et al. Early-life gut microbiome modulation reduces the abundance of antibiotic-resistant bacteria. Antimicrob. Resist. Infect. Control 8, 131 (2019).

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Contributions

D.H.T. and A.W.T. co-wrote the initial outline for this paper. D.H.T wrote the initial draft of this manuscript, and both edited the manuscript until it reached its present form. Both authors approved the final draft.

Corresponding author

Correspondence to Diana H. Taft.

Ethics declarations

Competing interests

The authors declare no competing interests.

Additional information

Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and Permissions

About this article

Verify currency and authenticity via CrossMark

Cite this article

Thorman, A.W., Taft, D.H. Using difference-in-difference to understand the downside to antibiotic use during infancy. Pediatr Res (2022). https://doi.org/10.1038/s41390-022-02280-9

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • DOI: https://doi.org/10.1038/s41390-022-02280-9

Search

Quick links